Aerie sets IPO range

Ophthalmic company Aerie Pharmaceuticals Inc. (Bedminster, N.J.) amended its IPO and said it hopes to sell 5.3 million shares at $12-$14. At the $13 midpoint, the company would raise $68.3 million and be valued at $264.2 million. RBC Capital Markets; Stifel; Lazard; and Canaccord are underwriters. Aerie filed to raise up to $57.5 million in the IPO in September. ...